EMA Recommends Granting a Marketing Authorisation for Generic Trabectedin By Ogkologos - April 30, 2025 431 0 Facebook Twitter Google+ Pinterest WhatsApp Trabectedin Accord is a generic of Yondelis, which has been authorised in the EU since 2007 Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk in Patients with MIBC MOST POPULAR Maintenance Olaparib in Elderly Patients With a Germline BRCA Mutation and... July 1, 2020 The Most Successful Female Singer Of The 1970s Disappeared. Now She’s... May 1, 2019 Coronavirus reports: “As a Black man with advanced prostate cancer, who... June 26, 2020 How to Make a Homemade Face Mask from a Folded Scarf—No... April 29, 2020 Load more HOT NEWS Let’s Talk About Bubbles Your questions on our research strategy Breaking News: The Healthcare Marketplace Re-opens TODAY! ΝΕΥΡΟΕΝΔΟΚΡΙΝΕΙΣ ΟΓΚΟΙ (ΝΕΤS)
